Company news
Tsh Biopharm Corp. Ltd. (TPEX:8432) news
Tsh Biopharm Corp. Ltd. news releases on 6ix. Latest, Aug 4, 2022: TSH Biopharm : Board of Directors Approved Financial Statements For the Six Months Ended…
Press releases & updates
TSH Biopharm : Board of Directors Approved Financial Statements For the Six Months Ended June 30, 2022
August 4, 2022
TSH Biopharm : Announcement of the Company’s list of newly elected independent director
May 24, 2022
TSH Biopharm : Announcement of Change to Remuneration Committee member
May 24, 2022
TSH Biopharm : Announcement of Change to Audit Committee member
May 24, 2022
TSH Biopharm : Announcement of the Ex-dividend Record Date of Cash Dividends
May 24, 2022
TSH Biopharm : Important resolutions of the Company's 2022 General Shareholders' Meeting
May 24, 2022
TSH Biopharm : Resignation of the vice general manager of General Administration Division, spokesperson and corporate governance officer of the Company
April 29, 2022
TSH Biopharm : Board of Directors resolved to convene the 2022 Annual General Shareholders' Meeting
March 4, 2022
TSH Biopharm : Board of Directors' Resolution on Distribution of 2021 Earnings
March 4, 2022
TSH Biopharm : Board of Directors Approved Financial Statements For the Year Ended December 31, 2021
March 4, 2022